Vi-Tetanus Toxoid Conjugate Vaccine Can Prevent Typhoid

Share this content:
Vi-Tetanus Toxoid Conjugate Vaccine Can Prevent Typhoid
Vi-Tetanus Toxoid Conjugate Vaccine Can Prevent Typhoid

FRIDAY, Sept. 29, 2017 (HealthDay News) -- A Vi-tetanus toxoid conjugate vaccine is efficacious for prevention of typhoid fever, according to a study published online Sept. 28 in The Lancet.

Celina Jin, M.B.B.S., from the University of Oxford in the United Kingdom, and colleagues examined the efficacy of a Vi-tetanus toxoid conjugate vaccine using an established human infection model of Salmonella enterica serovar Typhi (S Typhi). Healthy adult volunteers (aged 18 to 60 years) were recruited and randomized in a 1-to-1-to-1 ratio to receive a single dose of Vi-conjugate (Vi-TT; 37 participants), Vi-polysaccharide (Vi-PS; 35 participants), or control meningococcal vaccine (31 participants). Participants orally ingested S Typhi and were assessed with daily blood culture over a two-week period.

The researchers found that 77, 35, and 35 percent of participants in the control, Vi-TT, and Vi-PS groups met the composite criteria for typhoid diagnosis, respectively, giving vaccine efficacies of 54.6 and 52 percent for Vi-TT and Vi-PS. In Vi-TT and Vi-PS participants, seroconversion was 100 and 88.6 percent, respectively; Vi-TT vaccine recipients had significantly higher geometric mean titers detected one month post-vaccination.

"Vi-TT is a highly immunogenic vaccine that significantly reduces typhoid fever cases when assessed using a stringent controlled model of typhoid infection," the authors write. "Vi-TT use has the potential to reduce both the burden of typhoid fever and associated health inequality."

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

ACG: Diphenhydramine Ups Sedation in Chronic Opioid Users

ACG: Diphenhydramine Ups Sedation in Chronic Opioid Users

Improvement in sedation scores for patients using chronic opioids scheduled to undergo colonoscopy

Online Ratings Not Aligned With Objective Quality Measures

Online Ratings Not Aligned With Objective Quality Measures

In addition, consumer ratings are consistent across platforms for specialist physicians

Most Female Physicians Have Faced Sexist Patient Comments

Most Female Physicians Have Faced Sexist Patient Comments

Sexual harassment by patients can negatively affect physician-patient relationship, quality of care

is free, fast, and customized just for you!

Already a member?

Sign In Now »